Please assess the completion status of the following clinical trial:

Trial Title: Study on Fistuloplasty Using Flow Measurement Guidance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or non-pregnant female subjects, between the ages of 18 and 80 at the time of enrollment.~* Subjects referred to us from the Dialysis units located in the study centres for clinically indicated fistulogram and fistula treatment.~* Written informed consent to participate in the study.~* Ability to comply with the requirements of the study procedures~Exclusion Criteria:~* Significant coagulopathy that cannot be adequately corrected.~* Subjects who participated in an active stage of any drug, intervention or treatment trial within 30 days of enrollment.~* Subjects with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study. Patients will only be excluded on this basis following discussion with another interventional radiologist and the referring nephrologist.~* Subjects who are uncooperative or cannot follow instructions.~* Mental state that may preclude completion of the study procedure or ability to obtain informed consent.~* Pregnant or nursing female subjects.~* Patients whose fistulae have never become functional.~* Patients with PTFE grafts/non-native fistulae~* Patients who have had previous stenting of fistulae

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Transonics Arm (Type: EXPERIMENTAL): Intervention will be guided by flow through the fistula as guided by Transonics flow measurements
- Control arm (Type: NO_INTERVENTION): Patient will undergo normal fistula intervention guided only by angiographic assessment

Based on this trial design, predict the completion outcome and termination type (if applicable).